Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close.

About Standard BioTools Inc.

Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook ® , LinkedIn, and YouTube™.

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms .
Patent and License Information: standardbio.com/legal/notices .
©2025 Standard BioTools Inc. All rights reserved.

Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.

Investor Contact:
ir@standardbio.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Standard BioToolsLABNGS:LABbiotech investing
LAB
The Conversation (0)
Excalibur Intersects 360 g/t Silver & 2 g/t Gold over 1.52m at Bellehelen; 100m Broad Mineralized Zone Remains Open at Depth

Excalibur Intersects 360 g/t Silver & 2 g/t Gold over 1.52m at Bellehelen; 100m Broad Mineralized Zone Remains Open at Depth

Excalibur Metals Corp. (TSXV: EXCL,OTC:EXCBF) (OTCQB: EXCBF) ("Excalibur" or the "Company") is pleased to announce partial drill results from the recently completed maiden drill program at the Company's flagship Bellehelen Silver-Gold Project ("Bellehelen" or the "Project") in Nye County,... Keep Reading...
Pinnacle Receives More Positive Results from Second Round of Scoping Metallurgical Tests at El Potrero with Average Gold Recovery of 97.8% for the Main Dos de Mayo Vein

Pinnacle Receives More Positive Results from Second Round of Scoping Metallurgical Tests at El Potrero with Average Gold Recovery of 97.8% for the Main Dos de Mayo Vein

(TheNewswire) VANCOUVER, BRITISH COLUMBIA TheNewswire - June 2, 2026 - (TSXV: PINN,OTC:PSGCF, OTCQB: PSGCF, Frankfurt: P9J) Pinnacle Silver and Gold Corp. ("Pinnacle" or the "Company") is pleased to provide more positive results from the second round of scoping metallurgical tests for the... Keep Reading...
Corcel Drills 56.65 Meters of 1.07% Cu, 0.79 g/t Au and 7.1 g/t Ag in the First Drill Hole at the Yuma King Project, Arizona

Corcel Drills 56.65 Meters of 1.07% Cu, 0.79 g/t Au and 7.1 g/t Ag in the First Drill Hole at the Yuma King Project, Arizona

Corcel Exploration Inc. (CSE: CRCL,OTC:CRLEF) (OTCQB: CRLEF) (the "Company" or "Corcel") is pleased to announce assay results from the first drill hole of the recently completed, Phase 1 drill program at the Yuma King Project (the "Project") located in west-central Arizona. Drill hole YK26-001... Keep Reading...
Brixton Metals Drills 2.3 m of 1,811 g/t Silver within 27.7 m of 166.45 g/t Silver at its Langis Project

Brixton Metals Drills 2.3 m of 1,811 g/t Silver within 27.7 m of 166.45 g/t Silver at its Langis Project

Brixton Metals Corporation (TSX-V: BBB, OTCQX: BBBXF) (the "Company" or "Brixton") is pleased to announce results from its ongoing exploration at the wholly owned Langis Silver Project, located in the historic silver mining camp of Cobalt, Ontario, Canada. The 2026 drill campaign marks a... Keep Reading...
Exploration Expands the High-Grade Silver-Lead Cate-8 Vein Discovered in the Upper Area of the Mine

Exploration Expands the High-Grade Silver-Lead Cate-8 Vein Discovered in the Upper Area of the Mine

Bunker Hill Mining Corp. ("Bunker Hill" or the "Company") (TSX: BNKR | OTCQB: BHLL) reports further successful results from the ongoing exploration drill program testing the high-grade silver-lead Cate-8 Vein discovery adjacent to current development in the upper area of the Bunker Hill mine... Keep Reading...
Doctor holds tablet displaying digital human body with health data, overlaid with medical icons.

Immunotherapy Innovations: Increasing Survival in Metastatic Breast Cancer

Metastatic breast cancer (MBC) remains incurable, with approximately only one-third of diagnosed women meeting the five year survival rate.Subtypes like triple-negative breast cancer (TNBC) or heavily pretreated hormone receptor-positive disease often come with more treatment challenges, leading... Keep Reading...
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program

Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program

KELOWNA, BC / ACCESS Newswire / June 3, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, announces that it is attending the BIO International Convention ("BIO") from June 22-25 in San Diego, CA. Lexaria's attendance... Keep Reading...
Collage with hands holding shiny DNA molecule on blue background.

5 Biggest Biotechnology ETFs in 2026

The biotech sector has made significant strides in recent years, and the market's volatility can increase the appeal of biotech ETFs. Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded... Keep Reading...
Doctor holding stethoscope over digital document interface

Beyond the Lab: Top-Tier Clinical Validation in Biotech Investing

Nature Medicine’s “Eleven Clinical Trials That Will Shape Medicine in 2026” highlights studies poised to influence patient care. Among the oncology selections, BriaCell Therapeutics' (TSX:BCT,NASDAQ:BCTX) pivotal Phase 3 trial of Bria-IMT™ stands out as a rare entry. This feature underscores the... Keep Reading...
BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Announces Closing of Offering

briacell therapeutics corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the closing of its best-efforts offering of 1,449,300 common shares. Each common... Keep Reading...
BriaCell Presents Positive Clinical Data at ASCO 2026

BriaCell Presents Positive Clinical Data at ASCO 2026

Final Bria-IMT™ Phase 2 data show 55% >1 year and 27% >2-year survival in heavily pre-treated metastatic breast cancer (MBC) patients treated with Bria-IMT regimen selected for Phase 3TWiST analysis, which measures time without disease symptoms or significant treatment-related toxicity, showed... Keep Reading...

Latest News

More News

Interactive Chart

Latest Press Releases

Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services

Nine Mile Metals Commences Trading on the OTCID Market, Expanding Access for U.S. Investors

America's Antimony Gap Is Washington's Problem -- and NevGold Is Racing to Help Close It

QIMC Highlights Technical Advisory Role on First Atlas Matane Natural Hydrogen Project Following Quebec Parliamentary Committee Appearance

Related News

copper investing

Top 5 Canadian Mining Stocks This Week: Tintina Mines Soars 200 Percent

gold investing

Editor's Picks: Gold, Silver Prices Take a Hit, Russia Makes Bold Gold Claim

precious metals investing

Blue Jay Gold Corp. Announces Engagement of Oak Hill Financial Inc. for Investor Relations and Retention of Haywood Securities for Market Making Services

copper investing

Nine Mile Metals Commences Trading on the OTCID Market, Expanding Access for U.S. Investors

silver investing

Sunshine Silver Mining Shares Jump 11 Percent in NYSE Debut

gold investing

Russia Claims Record Gold Output as Production Estimates Diverge

precious metals investing

America's Antimony Gap Is Washington's Problem -- and NevGold Is Racing to Help Close It